Adcetris-Gemcitabine Combo Eliminates Cancer in Two-thirds of Hodgkin’s Lymphoma Patients in Phase 1/2 Trial
News
A combination of Adcetris (brentuximab vedotin) and the chemotherapy gemcitabine completely eliminated the tumors in two out of three children and young adults with Hodgkin’s lymphoma in a Phase 1/2 ... Read more